T1	Treatment 44 58	interleukin-10
T2	Treatment 774 821	a lentivirus delivering human IL-10 (LV/hIL-10)
T3	Treatment 1101 1164	Group CCI±Normal Saline (NS), Group CCI±LV/hIL-10 (LV/hIL-10)
T4	Treatment 1170 1200	Group CCI±LV/control (vector)
T5	Treatment 1250 1302	with NS, LV/control, or recombinant vector LV/hIL-10
T6	Treatment 2129 2160	show that intrathecal LV/hIL-10
T7	Treatment 2833 2844	transfer of
